|
|
|
|
| LEADER |
00000nam a22000007i 4500 |
| 001 |
SCIDIR_on1403831186 |
| 003 |
OCoLC |
| 005 |
20231120010756.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
231016s2024 enk o 000 0 eng d |
| 040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d OCLCO
|
| 020 |
|
|
|a 0443189269
|q (electronic bk.)
|
| 020 |
|
|
|a 9780443189265
|q (electronic bk.)
|
| 020 |
|
|
|z 9780443189258
|
| 035 |
|
|
|a (OCoLC)1403831186
|
| 050 |
|
4 |
|a RM666.P415
|
| 082 |
0 |
4 |
|a 615.6
|2 23/eng/20231016
|
| 245 |
0 |
0 |
|a Peptide and protein drug delivery using polysaccharides /
|c edited by Aakanchha Jain, Sonia Malik.
|
| 264 |
|
1 |
|a London, United Kingdom :
|b Academic Press,
|c [2024].
|
| 300 |
|
|
|a 1 online resource (400 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 650 |
|
0 |
|a Peptide drugs
|x Dosage forms.
|
| 650 |
|
0 |
|a Protein drugs
|x Dosage forms.
|
| 650 |
|
0 |
|a Polysaccharides
|x Therapeutic use.
|
| 650 |
|
6 |
|a M�edicaments peptidiques
|x Formes pharmaceutiques.
|0 (CaQQLa)201-0263775
|
| 650 |
|
6 |
|a M�edicaments prot�eiques
|x Formes pharmaceutiques.
|0 (CaQQLa)201-0263778
|
| 650 |
|
6 |
|a Polysaccharides
|0 (CaQQLa)201-0011180
|x Emploi en th�erapeutique.
|0 (CaQQLa)201-0373975
|
| 700 |
1 |
|
|a Jain, Aakanchha,
|e editor.
|
| 700 |
1 |
|
|a Malik, Sonia,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t PEPTIDE AND PROTEIN DRUG DELIVERY USING POLYSACCHARIDES.
|d [Place of publication not identified] : ELSEVIER ACADEMIC PRESS, 2023
|z 0443189250
|w (OCoLC)1371137824
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780443189258
|z Texto completo
|
